Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 13/20 | 0.51 |
| ▸ | KDM5B | Q9UGL1 | 8/20 | 0.51 |
| ▸ | KDM5A | P29375 | 5/20 | 0.51 |
| ▸ | MEN1 | O00255 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | THRB | P10828 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | KDM2B | Q8NHM5 | 3/20 | 0.46 |
| ▸ | KDM4A | O75164 | 4/20 | 0.44 |
| ▸ | RECQL | P46063 | 2/20 | 0.42 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20830149 | 0.86 | KDM4C (0.51) | KDM4CKDM5BKDM5AMEN1KMT2A | |
| SCHEMBL20819200 | 0.83 | KMT2A (0.51) | KDM4CKDM5BKDM5AMEN1KMT2A | |
| SCHEMBL20830327 | 0.82 | KDM4C (0.46) | KDM4CKDM5BKDM5AMEN1KMT2A | |
| SCHEMBL20830152 | 0.80 | KDM4C (0.48) | KDM4CKDM5BKDM5AMEN1KMT2A | |
| SCHEMBL20830314 | 0.80 | KMT2A (0.46) | KDM4CKDM5BKDM5AMEN1KMT2A | |
| SCHEMBL20830154 | 0.76 | KMT2A (0.41) | KDM4CKDM5BKDM5AMEN1KMT2A | |
| SCHEMBL20830294 | 0.73 | NOX4 (0.47) | KDM4CKDM5BKDM5AMEN1KMT2A | |
| SCHEMBL19918060 | 0.72 | KMT2A (0.75) | MEN1KMT2AKDM4EGAAMAPT | |
| SCHEMBL20830150 | 0.71 | KDM4E (0.47) | MEN1KMT2AKDM4EGAAMAPT | |
| SCHEMBL20830295 | 0.70 | RAB9A (0.46) | KDM4CKDM5BKDM5AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200308165-A1 | Compounds as Ras Inhibitors and Use Thereof | D. E. SHAW RESEARCH, LLC | 2020-10-01 | — | — | US | disclosed |
| US-20200308165-A1 | Compounds as Ras Inhibitors and Use Thereof | D. E. SHAW RESEARCH, LLC | 2020-10-01 | — | — | US | disclosed |
| WO-2019055540-A1 | COMPOUNDS AS RAS INHIBITORS AND USE THEREOF | D.E. SHAW RESEARCH, LLC (US) | 2019-03-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200308165-A1 | Compounds as Ras Inhibitors and Use Thereof | KRAS, NRAS, HRAS | KDM4C 4378/4885KDM5B 4047/4885KDM5A 4302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.